Innovation Pharmaceuticals Inc (IPIX)

[Cognition]

Is yesterday’s PR about K combined with Dr. B’s quote from over a month ago telling us something about the status of P’s 2b data?

“Near-term strategic clinical priorities remain: to work closely with the FDA and other regulatory authorities to align on the remaining development plan necessary for Brilacidin in Oral Mucositis; to analyze the Prurisol Phase 2b data in Psoriasis; and, as additional funding becomes available, to commence work on new product formulations—1) an oral pill for Kevetrin in Ovarian Cancer; 2) an oral pill for Brilacidin in IBD; and a topical application for Brilacidin in Atopic Dermatitis and Acne.”

I think we’ll be hearing something soon IMO.